Press Release HOME > NEWS > Press Release PharmCADD showed proprietary AI technology at Medicine-Bio Forum 2022. READ MORE PharmCADD was selected into the KOREA AI STARTUP 100 list. READ MORE PharmCADD participated in AI KOREA 2022. READ MORE “AI” will accellerate the drug developement. READ MORE PharmCADD won “2022 AI KOREA Awards” from The Ministry of Trade, Industry and Energy. READ MORE PharmCADD & ISU ABXIS jointly develop a medicine for the treatment of neurofibromatosis type 1 (NFI) READ MORE “Break the New Drug development limits through AI based on Quantum Mechanics.” READ MORE Top 50 Pharma-Bio Companies, Started Quantum Jump by developing New AI Drugs. READ MORE Dr. Sangwook Wu introduced potential platform technologies. READ MORE « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Next »
PharmCADD & ISU ABXIS jointly develop a medicine for the treatment of neurofibromatosis type 1 (NFI) READ MORE